NVCT (Nuvectis Pharma) Buyback Yield %: -2.34 (As of Jul. 03, 2026)


NVCT Nuvectis Pharma Inc NVCT
26 GF Score
Price $19.57
! 1 Warning Sign
View Full Analysis

What is Nuvectis Pharma Buyback Yield %?

Nuvectis Pharma NVCT +0.15% 26 Buyback Yield % is -2.34 as of Jul. 03, 2026. GuruFocus rates NVCT with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 744 Biotechnology companies, Nuvectis Pharma ranks better than 68.01% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Nuvectis Pharma's current buyback yield was -2.34%.

Nuvectis Pharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Nuvectis Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvectis Pharma Buyback Yield % Chart

Nuvectis Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial 0.00 -29.03 -3.64 -11.41 -16.10

Nuvectis Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.39 -12.82 -22.62 -16.10 -7.03

NVCT vs AURA, OCS, CADL: Buyback Yield % Comparison

For the Biotechnology subindustry, Nuvectis Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvectis Pharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvectis Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Nuvectis Pharma's Buyback Yield % falls into.


NVCT
26GF Score
Nuvectis Pharma Inc NVCT
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvectis Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Nuvectis Pharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 31.21) / 193.86135
=-16.10%

Nuvectis Pharma's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 14.419) / 205.04598
=-7.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -2.34 mean?
Nuvectis Pharma (NVCT) has a Buyback Yield % of -2.34 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Nuvectis Pharma and its competitors. According to the industry distribution chart, Nuvectis Pharma ranks #238 out of 744 companies in the Biotechnology industry, placing it in the top 32%.
Is Nuvectis Pharma's Buyback Yield % too high?
Nuvectis Pharma's current Buyback Yield % is -2.34. Based on the distribution chart, Nuvectis Pharma ranks #238 out of 744 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nuvectis Pharma has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Nuvectis Pharma's Buyback Yield % compare to AURA and OCS?
According to the Biotechnology industry distribution chart, Nuvectis Pharma ranks #238 out of 744 companies for Buyback Yield %. This puts Nuvectis Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Nuvectis Pharma and its competitors. Nuvectis Pharma's current Buyback Yield % is -2.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvectis Pharma stock overvalued right now?
Nuvectis Pharma (NVCT) has a current Buyback Yield % of -2.34. The current Buyback Yield % is -2.34. Nuvectis Pharma's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Nuvectis Pharma (NVCT), the current Buyback Yield % is -2.34 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuvectis Pharma Business Description

Address 1 Bridge Plaza, 2nd Floor, Suite 275, Fort Lee, NJ, USA, 07024
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
26GF Score

Get the complete analysis for NVCT

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.57
Price